Related Experiment Video
Updated: Feb 2, 2026

Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test
Published on: November 13, 2016
Sodium-glucose cotransporter 2 inhibitors regulate ketone body metabolism via inter-organ crosstalk
Jin Hee Kim1,2, Minyoung Lee2,3, Soo Hyun Kim2
1Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, Republic of Korea.
Aim:
To investigate sodium-glucose cotransporter 2 inhibitor (SGLT2i)-induced changes in ketogenic enzymes and transporters in normal and diabetic mice models.
Materials And Methods:
Normal mice were randomly assigned to receive either vehicle or SGLT2i (25 mg/kg/d by oral gavage) for 7 days. Diabetic mice were treated with vehicle, insulin (4.5 units/kg/d by subcutaneous injection) or SGLT2i (25 mg/kg/d by intra-peritoneal injection) for 5 weeks. Serum and tissues of ketogenic organs were analysed.
Results:
In both normal and diabetic mice, SGLT2i increased beta-hydroxybutyrate (BHB) content in liver, kidney and colon tissue, as well as in serum and urine. In these organs, SGLT2i upregulated mRNA expression of ketogenic enzymes, 3-hydroxy-3-methylglutaryl-coenzyme A synthase 2 and 3-hydroxy-3-methylglutaryl-coenzyme A lyase. Similar patterns were observed in the kidney, ileum and colon for mRNA and protein expression of sodium-dependent monocarboxylate transporters (SMCTs), which mediate the cellular uptake of BHB and butyrate, an important substrate for intestinal ketogenesis. In diabetic mice under euglycaemic conditions, SGLT2i increased major ketogenic enzymes and SMCTs, while insulin suppressed ketogenesis.
Conclusions:
SGLT2i increased systemic and tissue BHB levels by upregulating ketogenic enzymes and transporters in the liver, kidney and intestine, suggesting the integrated physiological consequences for ketone body metabolism of SGLT2i administration.
Insights
Sodium-glucose cotransporter 2 inhibitors (SGLT2i) boost ketone production in mice by increasing ketogenic enzymes and transporters in the liver, kidney, and intestine. This highlights SGLT2i
Area of Science:
- Metabolic Physiology
- Pharmacology
- Endocrinology
Background:
- Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are used to manage type 2 diabetes.
- The impact of SGLT2i on ketone body metabolism is not fully understood.
- Ketogenesis is a critical metabolic pathway involving the liver, kidney, and intestine.
Purpose of the Study:
- To investigate the effects of SGLT2i on ketogenic enzymes and transporters.
- To compare SGLT2i effects with insulin in diabetic models.
- To elucidate the physiological consequences of SGLT2i on ketone metabolism.
Main Methods:
- Utilized normal and diabetic mouse models.
- Administered SGLT2i or insulin via oral gavage or injection.
- Analyzed serum and tissue samples from ketogenic organs for enzyme and transporter expression.
Main Results:
- SGLT2i increased beta-hydroxybutyrate (BHB) levels in serum and multiple tissues (liver, kidney, colon).
- Upregulation of ketogenic enzymes (3-hydroxy-3-methylglutaryl-coenzyme A synthase 2, 3-hydroxy-3-methylglutaryl-coenzyme A lyase) and sodium-dependent monocarboxylate transporters (SMCTs) was observed.
- Insulin suppressed ketogenesis in diabetic mice, contrasting with SGLT2i's ketogenic effects.
Conclusions:
- SGLT2i enhances systemic and tissue BHB levels by upregulating key ketogenic enzymes and transporters.
- These findings suggest integrated physiological effects of SGLT2i on ketone body metabolism.
- SGLT2i promotes ketogenesis, while insulin has an inhibitory effect in diabetic conditions.
More Related Videos
08:13Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
10:35Extracellular Glucose Depletion as an Indirect Measure of Glucose Uptake in Cells and Tissues Ex Vivo
Published on: April 6, 2022
Related Concept Videos
Regulation of Sodium and Potassium
Sodium Regulation
Sodium ions make up approximately 90% of extracellular cations, with a normal blood plasma concentration of 136–148 mEq/L. A decrease in blood volume and pressure triggers the release of renin from granular cells in the juxtaglomerular complex (JGC), primarily...
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Regulation of Metabolism
Metabolic States of the Body: The Absorptive State
Metabolic States of the Body: The Postabsorptive State
Initially, glycogen stored in the liver is broken down to release glucose into the bloodstream, while glycogen in the muscles is broken down to supply glucose for energy directly within the muscle cells. As glycogen stores diminish,...
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...